Companies · Other Health Care

Assure Holdings Corp.

DENVER · Other Health Care

Diligence memoA one-page analyst read on Assure Holdings Corp. — recommendation, valuation, rhythm, risks.
$13.1M
Total raised · real
5
Rounds
0.0×
Latest step-up
Top 22%
Sector rank · raised
Series A
Latest stage · inferred · Fri Nov 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Assure Holdings Corp. looks under-valued against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.07× the median modeled value of Series A Other Health Care companies in 2022–2024 (196 peers) — value vs value, same stage and era.
At-risk
  • Last raise 3.6 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Assure Holdings Corp. behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
6.6 yr record
Peak capital year was 2020 with $11.1M across 3 filings.
Market position
ahead of 79% of Other Health Care peers
Capital scale is ahead of 79% of Other Health Care peers; modeled value is above 11% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2020: $11.1M across 3 filings.
  • Largest single filing was $10.5M on 2020-12-02.
  • Filing rows sum to $15.6M, while canonical raised total is $13.1M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Assure Holdings Corp. is one of 5377 Other Health Care companies tracked from DENVER. By capital raised it ranks in the upper tier (ahead of 79% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
14
Investors (latest)
2022-11-18
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeed · 2019-12-13 Raised $1.5M (real) Modeled valuation $38M (est)Seed2019Pre-Seed · 2019-12-13 Raised $915K (real) Modeled valuation $28M (est)Pre-Seed2019Seed · 2019-12-13 Raised $1.8M (real) Modeled valuation $43M (est)Seed2019Seed · 2020-05-11 Raised $500K (real) Modeled valuation $12M (est)Seed2020Seed · 2020-07-13 Raised $102K (real) Modeled valuation $2.5M (est)Seed2020Series A · 2020-12-02 Raised $10M (real) Modeled valuation $182M (est)Series A2020Series A · 2022-11-18 Raised $308K (real) Modeled valuation $2.6M (est)Series A2022+$915K+$1.8M+$500K+$102K+$10M+$308KCumulative $16M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.5M · 2019
Bridge · Seed-stage$915K · 2019smaller follow-on
Seed extension$1.8M · 2019
Seed extension$500K · 2020
Seed extension$102K · 2020
Series A$10.5M · 2020
Series A extension$308K · 2022

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$2.6M
Base estimate est.
$394K
Conservative case
$8.3M
Upside case
$1.4M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $38.1M · 2019-12-132019Pre-Seed · modeled $28.2M · 2019-12-13Seed · modeled $43.5M · 2019-12-13Seed · modeled $12.4M · 2020-05-11Seed · modeled $2.5M · 2020-07-13Series A · modeled $181.7M · 2020-12-02Series A · modeled $2.6M · 2022-11-182022
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
3.6 yr
Elapsed time used
3.6 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
6 mo
Avg between rounds
$4.5M/yr
Capital velocity
6.6 yr
On record since
2019
First round
7
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 5.4× above median
This company$13.1M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.1× of median
This company$308K
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 0.1× of median
This company$2.6M
Sector median$22.1M

Raised more than 79% of sector peers (real $). Modeled value above 11% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #187 of 196.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0B$1.0M$10.0M$100.0MCapital raised (log)CareHarmony, Inc. · Series A Raised $17.4M · modeled $145.2M (est)Dragonfly Endoscopy Inc. · Series A Raised $12.7M · modeled $142.0M (est)NuvoAir Holdings, Inc. · Series A Raised $10.7M · modeled $125.1M (est)Post Acute Recovery, Inc. · Series A Raised $14.5M · modeled $123.0M (est)Micro Interventional Devices, Inc. · Series A Raised $14.0M · modeled $119.0M (est)Etiometry Inc. · Series A Raised $15.6M · modeled $114.7M (est)SafKan, Inc. · Series A Raised $13.0M · modeled $108.5M (est)BehaVR Holdings, Inc. · Series A Raised $12.1M · modeled $102.1M (est)Outliers Inc. · Series A Raised $13.6M · modeled $101.7M (est)RevMedica, Inc. · Series A Raised $14.2M · modeled $101.2M (est)Innovoyce LLC · Series A Raised $9.9M · modeled $97.6M (est)Prixz, Inc. · Series A Raised $9.2M · modeled $97.4M (est)Assure Holdings Corp. (this company) Raised $13.1M · modeled $2.6M (est)Assure Holdings Corp.
CompanyStageRaised · realValue · estvs peer med.
CareHarmony, Inc.Series A$17.4M$145.2M3.96×
Dragonfly Endoscopy Inc.Series A$12.7M$142.0M3.87×
NuvoAir Holdings, Inc.Series A$10.7M$125.1M3.41×
Post Acute Recovery, Inc.Series A$14.5M$123.0M3.35×
Micro Interventional Devices, Inc.Series A$14.0M$119.0M3.25×
Etiometry Inc.Series A$15.6M$114.7M3.13×
SafKan, Inc.Series A$13.0M$108.5M2.96×
BehaVR Holdings, Inc.Series A$12.1M$102.1M2.78×
Outliers Inc.Series A$13.6M$101.7M2.77×
RevMedica, Inc.Series A$14.2M$101.2M2.76×
Innovoyce LLCSeries A$9.9M$97.6M2.66×
Prixz, Inc.Series A$9.2M$97.4M2.66×
Assure Holdings Corp. this companySeries A$13.1M$2.6M0.07×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.5M2019-12-13$7.7M$38.1M90%
Pre-Seed$915K2019-12-13$5.1M$28.2M90%
Seed$1.8M2019-12-13$8.8M$43.5M90%
Seed$500K2020-05-11$2.5M$12.4M90%
Seed$102K2020-07-13$510K$2.5M90%
Series A$10.5M2020-12-02$47.6M$181.7M90%
Series A$308K2022-11-18$1.4M$2.6M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.5M2019-12-13
    • First recorded raise — entered as Seed.
    • 5 investors on this round.
  2. Pre-Seed$915K2019-12-13
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.7× smaller than the prior — bridge or down round.
    • 5 investors on this round.
  3. Seed$1.8M2019-12-13
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.9× larger than the prior — scaling up.
    • 18 investors on this round.
  4. Seed$500K2020-05-11
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round 3.5× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  5. Seed$102K2020-07-13
    • Came back fast: 2 mo vs the ~14 mo sector norm.
    • Round 4.9× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  6. Series A$10.5M2020-12-02
    • Came back fast: 5 mo vs the ~14 mo sector norm.
    • Round 102.6× larger than the prior — scaling up.
    • 18 investors on this round.
  7. Series A$308K2022-11-18
    • Raised again after 24 mo — slower than the ~14 mo sector norm.
    • Round 34.0× smaller than the prior — bridge or down round.
    • 14 investors on this round.
Intelligence
2023 ~Q2
Modeled next raise · ~6mo cadence
$308K
Modeled next size est.range $308K$492K
0.0×
Last step-up
$4.5M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
John Price7 other2020-12
Martin Burian2 other2019-12
Christopher Rumana1 other2019-12
John Flood1 other2022-11
Scott Kozak1 other2019-12
Alex Rasmussen2019-12
Gary Bennett2020-12
John Farlinger2019-12
Paul Webster2020-12
Preston Parsons2019-12
Scott Page2019-12
Sean Blosser2020-12
Stephanie Krouse2020-12
Steven Summer2019-12
Trent Carman2019-12
Registry & provenance

Assure Holdings Corp. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1798270
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Omeza Holdings, Inc.Other Health CareSeries A$13.8M$3.7Msame sector · same stage
Tegria RCM Group - US, Inc.Other Health CareSeries A$11.8M$2.0Msame sector · same stage
RF Surgical Systems, IncOther Health CareSeries A$14.6M$2.4Msame sector · same stage
South Campus Surgery Center LlcOther Health CareSeries A$15.3M$1.8Msame sector · same stage
Nymbl Science, Inc.Other Health CareSeries A$15.8M$3.1Msame sector · same stage
Wright Therapy Products, Inc.Other Health CareSeries A$10.1M$3.2Msame sector · same stage
Vast.Com Inc.OtherSeries A$14.0M$211.9Mnetwork1 shared operator · same stage
Family First, Inc.Other Health CareSeries A$18.6M$2.6Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
MedTrust Holdings, Inc.Other Health CareSeed$23.9M87%
Truth Holdings, L.P.Other Health CareSeries C$1.6B85%
OHEADS Propco Holdings LLCOther Health CareSeed$18.0M84%
Sees Holdings, LlcOther Health CareSeries C$996.9M84%
VPP Group Holdings, L.P.Other Health CareSeed$6.8M84%
V Shareholder Investments INc.Other Health CarePre-Seed$5.3M84%
AR CPT Holdings Inc.Other Health CareSeries B$105.9M84%
BestPractice Holdings, Inc.Other Health CarePre-Seed$280K84%
Frequently asked
How much funding has Assure Holdings Corp. raised?
Assure Holdings Corp. has raised approximately $13.1M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is Assure Holdings Corp.'s estimated valuation?
Provath's modeled valuation for Assure Holdings Corp. is approximately $2.6M (modeled range $394K–$8.3M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Assure Holdings Corp. at?
Assure Holdings Corp.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Fri Nov 18.
What does Assure Holdings Corp. do and where is it based?
Assure Holdings Corp. operates in the Other Health Care sector, based in DENVER.
Explore related

See where Assure Holdings Corp. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Assure Holdings Corp., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.